Increased apoptosis induction in CD4+CD25+ Foxp3 + T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation

N. Li, T. Ma, J. Han, J. Zhou, J. Wang, J. Zhang, S. Zheng

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

BACKGROUND: Abnormality in the number and function of regulatory T cells (Tregs) has been linked to initiation and progression in patients with Rheumatoid Arthritis (RA). AIM: This study aims to demonstrate the apoptosis status of regulatory T cells (Tregs) and its correlation with clinical activity of RA patients and the effect of interleukin-10 (IL-10) on Tregs apoptosis in RA. MATERIALS AND METHODS: Apoptosis rates and its related molecules including Fas, Bcl-2, Caspase-3 and Caspase-8 were examined using flow cytometry. The correlation between the apop-tosis level of Tregs and clinical activity parameters including ESR (erythrocyte sedimentation rate), CPR (C reactive protein), RF (Rheumatoid Factor) and DAS28 (Disease activity score 28) was analysed. PBMCs isolated from RA patients were cultured with IL-10 or anti-IL-10, and the apoptosis frequency of Tregs was then analyzed. RESULTS: The frequency of Tregs in active RA patients was decreased, and Fas, Caspase-3 and Caspase-8 expression on Tregs was much higher compared with the healthy subjects. The expression of anti-apoptotic protein, Bcl-2 on Tregs did not display significant changes between active RA patients and healthy subjects. There was a significantly positive correlation between the levels of apoptosis rates and Caspase-3 expression in Tregs and DAS28 of active RA patients. The apoptosis rates of Tregs in RA patients decreased or increased, respectively, following treatment with IL-10 or anti-IL-10 antibody in vitro. CONCLUSIONS: Apoptosis pathways are defective in Treg cells from RA patients with active disease. IL-10 treatment can modulate apoptosis in Tregs via extrinsic (type I) pathway, which may lead to restoration of the Tregs towards that of controlling autoimmune reaction in RA patients.

Original languageEnglish (US)
Pages (from-to)78-85
Number of pages8
JournalEuropean Review for Medical and Pharmacological Sciences
Volume18
Issue number1
StatePublished - 2014

Fingerprint

Interleukin-10
Rheumatoid Arthritis
Apoptosis
T-Lymphocytes
Regulatory T-Lymphocytes
Caspase 3
Caspase 8
Healthy Volunteers
Apoptosis Regulatory Proteins
Rheumatoid Factor
Blood Sedimentation
C-Reactive Protein
Flow Cytometry
Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

@article{e070525aa4644916a20eb860b0e56c58,
title = "Increased apoptosis induction in CD4+CD25+ Foxp3 + T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation",
abstract = "BACKGROUND: Abnormality in the number and function of regulatory T cells (Tregs) has been linked to initiation and progression in patients with Rheumatoid Arthritis (RA). AIM: This study aims to demonstrate the apoptosis status of regulatory T cells (Tregs) and its correlation with clinical activity of RA patients and the effect of interleukin-10 (IL-10) on Tregs apoptosis in RA. MATERIALS AND METHODS: Apoptosis rates and its related molecules including Fas, Bcl-2, Caspase-3 and Caspase-8 were examined using flow cytometry. The correlation between the apop-tosis level of Tregs and clinical activity parameters including ESR (erythrocyte sedimentation rate), CPR (C reactive protein), RF (Rheumatoid Factor) and DAS28 (Disease activity score 28) was analysed. PBMCs isolated from RA patients were cultured with IL-10 or anti-IL-10, and the apoptosis frequency of Tregs was then analyzed. RESULTS: The frequency of Tregs in active RA patients was decreased, and Fas, Caspase-3 and Caspase-8 expression on Tregs was much higher compared with the healthy subjects. The expression of anti-apoptotic protein, Bcl-2 on Tregs did not display significant changes between active RA patients and healthy subjects. There was a significantly positive correlation between the levels of apoptosis rates and Caspase-3 expression in Tregs and DAS28 of active RA patients. The apoptosis rates of Tregs in RA patients decreased or increased, respectively, following treatment with IL-10 or anti-IL-10 antibody in vitro. CONCLUSIONS: Apoptosis pathways are defective in Treg cells from RA patients with active disease. IL-10 treatment can modulate apoptosis in Tregs via extrinsic (type I) pathway, which may lead to restoration of the Tregs towards that of controlling autoimmune reaction in RA patients.",
author = "N. Li and T. Ma and J. Han and J. Zhou and J. Wang and J. Zhang and S. Zheng",
year = "2014",
language = "English (US)",
volume = "18",
pages = "78--85",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "1",

}

Increased apoptosis induction in CD4+CD25+ Foxp3 + T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation. / Li, N.; Ma, T.; Han, J.; Zhou, J.; Wang, J.; Zhang, J.; Zheng, S.

In: European Review for Medical and Pharmacological Sciences, Vol. 18, No. 1, 2014, p. 78-85.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increased apoptosis induction in CD4+CD25+ Foxp3 + T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation

AU - Li, N.

AU - Ma, T.

AU - Han, J.

AU - Zhou, J.

AU - Wang, J.

AU - Zhang, J.

AU - Zheng, S.

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Abnormality in the number and function of regulatory T cells (Tregs) has been linked to initiation and progression in patients with Rheumatoid Arthritis (RA). AIM: This study aims to demonstrate the apoptosis status of regulatory T cells (Tregs) and its correlation with clinical activity of RA patients and the effect of interleukin-10 (IL-10) on Tregs apoptosis in RA. MATERIALS AND METHODS: Apoptosis rates and its related molecules including Fas, Bcl-2, Caspase-3 and Caspase-8 were examined using flow cytometry. The correlation between the apop-tosis level of Tregs and clinical activity parameters including ESR (erythrocyte sedimentation rate), CPR (C reactive protein), RF (Rheumatoid Factor) and DAS28 (Disease activity score 28) was analysed. PBMCs isolated from RA patients were cultured with IL-10 or anti-IL-10, and the apoptosis frequency of Tregs was then analyzed. RESULTS: The frequency of Tregs in active RA patients was decreased, and Fas, Caspase-3 and Caspase-8 expression on Tregs was much higher compared with the healthy subjects. The expression of anti-apoptotic protein, Bcl-2 on Tregs did not display significant changes between active RA patients and healthy subjects. There was a significantly positive correlation between the levels of apoptosis rates and Caspase-3 expression in Tregs and DAS28 of active RA patients. The apoptosis rates of Tregs in RA patients decreased or increased, respectively, following treatment with IL-10 or anti-IL-10 antibody in vitro. CONCLUSIONS: Apoptosis pathways are defective in Treg cells from RA patients with active disease. IL-10 treatment can modulate apoptosis in Tregs via extrinsic (type I) pathway, which may lead to restoration of the Tregs towards that of controlling autoimmune reaction in RA patients.

AB - BACKGROUND: Abnormality in the number and function of regulatory T cells (Tregs) has been linked to initiation and progression in patients with Rheumatoid Arthritis (RA). AIM: This study aims to demonstrate the apoptosis status of regulatory T cells (Tregs) and its correlation with clinical activity of RA patients and the effect of interleukin-10 (IL-10) on Tregs apoptosis in RA. MATERIALS AND METHODS: Apoptosis rates and its related molecules including Fas, Bcl-2, Caspase-3 and Caspase-8 were examined using flow cytometry. The correlation between the apop-tosis level of Tregs and clinical activity parameters including ESR (erythrocyte sedimentation rate), CPR (C reactive protein), RF (Rheumatoid Factor) and DAS28 (Disease activity score 28) was analysed. PBMCs isolated from RA patients were cultured with IL-10 or anti-IL-10, and the apoptosis frequency of Tregs was then analyzed. RESULTS: The frequency of Tregs in active RA patients was decreased, and Fas, Caspase-3 and Caspase-8 expression on Tregs was much higher compared with the healthy subjects. The expression of anti-apoptotic protein, Bcl-2 on Tregs did not display significant changes between active RA patients and healthy subjects. There was a significantly positive correlation between the levels of apoptosis rates and Caspase-3 expression in Tregs and DAS28 of active RA patients. The apoptosis rates of Tregs in RA patients decreased or increased, respectively, following treatment with IL-10 or anti-IL-10 antibody in vitro. CONCLUSIONS: Apoptosis pathways are defective in Treg cells from RA patients with active disease. IL-10 treatment can modulate apoptosis in Tregs via extrinsic (type I) pathway, which may lead to restoration of the Tregs towards that of controlling autoimmune reaction in RA patients.

UR - http://www.scopus.com/inward/record.url?scp=84896924518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896924518&partnerID=8YFLogxK

M3 - Article

C2 - 24452947

AN - SCOPUS:84896924518

VL - 18

SP - 78

EP - 85

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 1

ER -